(Q29547178)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

2

Folkman J

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

author name string

Hanahan D

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

language of work or name

1 reference

23 April 2017

publication date

9 August 1996

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

volume

86

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

issue

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

23 April 2017

page(s)

353-64

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8756718

Transgenic models of tumor development.

23 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Angiogenesis inhibition: a review

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Inhibition of Cell Motility by Interferon

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Deregulation of both imprinted and expressed alleles of the insulin–like growth factor 2 gene during β–cell tumorigenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Angiogenesis: models and modulators.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

The 16K Fragment of Prolactin Specifically Inhibits Basal or Fibroblast Growth Factor Stimulated Growth of Capillary Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Transgenic and gene knockout mice in cancer research

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Tumor dormancy in vivo by prevention of neovascularization

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Cloning and characterization of a novel human gene related to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Microvessel density and distribution in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Dissecting multistep tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Transgenic mice as probes into complex systems

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Endothelial proliferation in tumours and normal tissues: Continuous labelling studies

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Bovine papillomavirus genome elicits skin tumours in transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Insulin-like Growth Factor II Is Focally Up-regulated and Functionally Involved as a Second Signal for Oncogene-induced Tumorigenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Differentiation of endothelium.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

1 reference

7 January 2021

Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Protamine is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Proliferation, senescence, and neoplastic progression of beta cells in hyperplasic pancreatic islets.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0092-8674(00)80108-7

7 January 2021